BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 23, 2014
View Archived Issues
OMP-59R5 proves active against metastatic pancreatic cancer
Read More
Metformin treatment regimen active in refractory colorectal cancer
Read More
Vivaldi Biosciences signs agreement with NIAID to develop live vaccine against H7N9
Read More
Zealand and Boehringer Ingelheim select new lead compound in diabetes collaboration
Read More
Nuevolution collaborates with the Institute of Cancer Research and Cancer Research Technology
Read More
Advaxis and Biocon to collaborate on novel cancer immunotherapy
Read More
Scioderm's epidermolysis bullosa therapy receives E.U. orphan drug designation
Read More
Novel agents for macular degeneration prepared at Novartis
Read More
EnVivo Pharmaceuticals initiates phase III trial program for encenicline in AD
Read More
The Alzheimer's Institute of America discloses new Nampt inhibitors
Read More
NICE recommends use of teriflunomide for MS
Read More
New ingenol derivatives prepared at Leo Laboratories
Read More
FDA issues complete response letter for Feraheme sNDA
Read More
Simcere Pharmaceutical R&D synthesizes novel K(v)7.2 channel activators
Read More
TotipotentRX and ThermoGenesis report data from phase Ib critical limb ischemia trial
Read More
Reata Pharmaceuticals and AbbVie begin phase I study of RTA-408 for NSCLC
Read More
Novel endothelial lipase inhibitor XEN-445 raises HDL cholesterol levels
Read More
Pfizer discloses novel LRRK2 inhibitors for Parkinson's disease
Read More
Companies sign agreements for darbepoetin alfa biosimilar in Japan
Read More
Aniona ApS designs new GABA(A) receptor modulators
Read More
FDA grants fast track status to BioAlliance's Validive
Read More
Generation of allosteric small-molecule phosphatase inhibitors for the treatment of cancer
Read More
Janssen forms new group to oversee global public health portfolio
Read More
Phase II trial of Prosonix's orally inhaled LAMA for COPD meets primary endpoint
Read More
First dose group recruited for phase II trial of THR-18 in acute stroke
Read More